Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma

NCT00523042 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

10

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description

Conditions

Diabetes
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Asthma

Interventions

DRUG: insulin aspart
DRUG: inhaled human insulin

Sponsor

Novo Nordisk A/S